Poster Presented at Association for Molecular Pathology Annual Meeting Highlights Potential to Improve Diagnostic Success…
The U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for simplSEQ’s…
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an…
Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that simplSEQ, an incubator company,…
The management team at SimplSeq is pleased to announce that it has received a $500,000…
SimplSeq, the company dedicated to simplifying the genomic sequencing workflow process, has announced that a…
SimplSeq, the company dedicated to simplifying the genomic sequencing workflow process, has retained digital marketing…
John C. Spinosa, M.D., Ph.D., has joined the executive management team as our Chief Medical…
On Friday, January 29th 2021, an article about SimplSEQ was published by GenomeWeb, an online…
SimplSEQ has filed its fourth patent application to protect our new sample preparation technology that…
Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new…
simplSEQ, the company dedicated to simplifying the genomic sequencing workflow process, has turned its attention…